亚洲国产一-亚洲国产系列一区二区三区-亚洲国产系列久久精品99人人-亚洲国产午夜精品乱码-国产在线精品99一卡2卡-国产在线黄色

普拉格雷150322-43-3

 
 
單價(jià) 面議對(duì)比
詢(xún)價(jià) 暫無(wú)
發(fā)貨 湖北武漢市付款后3天內(nèi)
過(guò)期 長(zhǎng)期有效
更新 2014-05-29 14:26
 

武漢楷倫化學(xué)新材料有限公司銷(xiāo)售部

企業(yè)會(huì)員第14年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明

普拉格雷
英文名  Prasugrel
英文化學(xué)名:

2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone
中文化學(xué)名:2-[2-(乙酰氧基)-6,7-二氫噻吩并[3,2-c]吡啶-5(4H)-]-1-環(huán)丙基-2-(2-氟苯基)乙酮

分子結(jié)構(gòu):


分子式:C20H20FNO3S
分子量:373.44
CAS
號(hào):150322-43-3

包裝:1kg,5kg

適應(yīng)癥:新型血栓預(yù)防藥物Effient(prasugrel,普拉格雷)用于預(yù)防接受經(jīng)皮冠狀動(dòng)脈介入(PCI)治療后的冠脈綜合癥患者的血栓形成。Effient幫助預(yù)防血小板凝聚成塊,在接受PCI手術(shù)后使用阿司匹林與Effient已證明可降低冠脈綜合癥患者發(fā)生心血管事件的風(fēng)險(xiǎn)。

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
鹽酸美金剛,美金剛胺用于抗老年癡呆癥藥物41100-52-1 羅氟司特中間體162401-62-9 替比培南側(cè)鏈179337-57-6 鹽酸決奈達(dá)隆141625-93-6 鹽酸二甲雙胍 氟比洛芬5104-49-4 富馬酸喹硫平(富馬酸喹的平)111974-72-2 氨甲環(huán)酸1197-18-8
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |